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Purpose: The aim of this study was to describe the imaging features of patients with invasive ductolobular
carcinoma of the breast in comparison with the proportion of the lobular component.
Materials and methods: We retrospectively reviewed mammographic, sonographic and MRI records of 113
patients with proven ductolobular carcinoma diagnosed between January 2008 and October 2012 according to the
BI-RADS ® lexicon, and correlated these to the proportion of the lobular component.
Results: At mammography the most common finding (62.9%) for invasive ductolobular carcinoma was an irregular,
spiculated and isodense mass. On ultrasound an irregular and hypoechoic mass, with spiculated margins and
posterior acoustic shadowing was observed in 46.8% of cases. Isolated mass and mass associated with non-mass like
enhancement (NMLE) were the most common findings by MRI (89.4%). Washout pattern in delayed phase was seen
in 61.2% and plateau curve was more frequently observed in patients with larger lobular component. Additional
malignant findings (multifocality, multicentricity and contralateral disease) did not correlate significantly with the
proportion of the lobular component.
Conclusion: Invasive ductolobular carcinoma mainly presents as an irregular, spiculated mass, isodense on
mammography and hypoechoic with posterior acoustic shadowing. On MRI it is usually seen as an isolated mass or
as a dominant mass surrounded by smaller masses or NMLE. Washout is the most ordinary kinetic pattern of these
tumors. In general, the imaging characteristics did not vary significantly with the proportion of the lobular
component.
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Breast cancer is a heterogeneous group of tumors with
multivariate morphology, growth pattern, molecular pro-
files and response to treatment. The majority of invasive
breast cancers (72 – 80%) are categorized as invasive
ductal carcinoma (IDC). The prevalence of the second
most common type of breast cancer, invasive lobular* Correspondence: G.DeLimaGomesdeMenezes@umcutrecht.nl
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in any medium, provided the original work is pcarcinoma (ILC), accounts for 5 to 15% (Biglia et al.
2007; Li et al. 2003; Verkooijen et al. 2003).
There is an extensive literature on clinical and imaging
characteristics of both IDC and ILC (Acs et al. 2001; Arps
et al. 2013; Brem et al. 2009; Kim et al. 2011; Korhonen
et al. 2004; Lopez & Bassett 2009; Sastre-Garau et al. 1996;
Winston et al. 2000; Yang et al. 2007). Multiple differences
in demographic and tumor features between these two
histological types have been reported. Patients with ILC are
generally older at the time of the diagnosis, (Sastre-Garau
et al. 1996; Moran et al. 2009) ILC is usually larger in diam-
eter, (Arpino et al. 2004; Biglia et al. 2013) is mores an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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Arpino et al. 2004) has lower grade than IDC, (Arps et al.
2013; Arpino et al. 2004; Biglia et al. 2013) is more fre-
quently multifocal, multicentric and bilateral, and the organ
distribution of metastatic disease tends to spread to pelvic
organs, gastrointestinal tract and also to distinct sites such
as retroperitoneum, meninges, ovary and serosa.
ILC has the histological characteristic to spread in rows of
single cell layers around normal ducts like a “spider web”,
infiltrating the preexisting stroma without inducing a strong
desmoplastic response (Michael et al. 2008; Qureshi et al.
2006). This growth pattern causes minimum disruption of
the normal anatomical structures than IDC, turning the
radiological and clinical diagnostic of this tumor into a real
challenge (Yeatman et al. 1995). This insidiously invasive na-
ture makes the full extent of these tumors difficult to diag-
nose in screening. Mammogram may only reveal subtle
changes or can even be completely normal. Mammographic
sensitivity for detection of ILC varies between 57-92%
(Butler et al. 1999; Hilleren et al. 1991a; Le et al. 1992) and
ILC has higher false negative rates than IDC (19 vs. 10%)
(Framarino Dei et al. 1995), making ILC more difficult to
diagnose, especially in early stage. Ultrasound (US) is slightly
more sensitive than mammography (sensitivity between 68-
95%) and has shown to be more accurate in determine the
(pathologic) size of the lesion, and also in identifying multi-
focality and multicentricity (Butler et al. 1999; Berg et al.
2004; Chapellier et al. 2000; Paramagul et al. 1995; Selinko
et al. 2004). Magnetic resonance imaging (MRI) has become
mainstream for diagnosis and work-up of breast cancer pa-
tients and many studies have demonstrated this imaging
modality to have sensitivity above 90% (Butler et al. 1999;
Berg et al. 2004; Chapellier et al. 2000; Boetes et al. 1995;
Boetes et al. 1997; Harms et al. 1993; Mumtaz et al. 1997;
Orel et al. 1994; Orel & Schnall 2001; Peters et al. 2008;
Qayyum et al. 2002; Rodenko et al. 1996). MRI plays a fun-
damental role in providing additional information not ob-
tained by conventional digital mammography and
ultrasound, being of great importance in recognition of ipsi-
lateral and contralateral lesions (Rodenko et al. 1996; Mann
et al. 2008). The MONET trial demonstrated that breast
MRI was associated with an increased re-excision rate and is
not advised to be used routinely for preoperative work-up of
patients with non-palpable breast cancer (Peters et al. 2011).
However, various authors proposed preoperative breast MRI
to have significant impact in treatment of patients with ILC
(Kim et al. 2011; Lopez & Bassett 2009; Michael et al. 2008;
Qayyum et al. 2002; Mann et al. 2008; Boetes et al. 2004;
Schelfout 2004). MRI has a superior accuracy (Berg et al.
2004; Boetes et al. 2004) in defining the extent of ILC and is,
therefore, essential for a correct surgical planning and fur-
ther treatment of these patients (Boetes et al. 1995; Orel
et al. 1994; Rodenko et al. 1996; Mann et al. 2008; Peters
et al. 2011; Lesser et al. 1982).Invasive ductolobular carcinoma, also called invasive
ductal carcinoma with lobular features (IDC-L), is inter-
mediate in the histological spectrum from ILC to IDC,
but the clinical and radiological presentation and behav-
ior of this histological type have not been widely studied.
It is therefore not well known if imaging features, clini-
copathologic behavior, and outcome of these tumors are
more comparable to IDC or to ILC.
The aim of this study was to therefore describe the
spectrum of mammographic, sonographic and MRI fea-
tures according to the BI-RADS® lexicon in patients with
histologically proven invasive ductolobular carcinoma of
the breast and to evaluate the relationship between the
proportion of the lobular component and the imaging
characteristics of these breast tumors.
Methods
Patients
Patients diagnosed with invasive breast carcinoma con-
taining lobular features at the UMC Utrecht (The
Netherlands) between January 2008 and October 2012
were considered. Only patients who underwent pre-
operative MRI, mammography and US were included in
this study.
Imaging acquisition
For the mammograms, the standard craniocaudal view
and mediolateral oblique were obtained using the Holo-
gic Lorad Selenia full field digital mammography system.
Additional views or spot compression were obtained
when necessary. The US images were acquired using a
Philips HD-11 XE digital imaging system (5–12 MHz
linear probe).
The MRI scans were acquired with the patient in the
prone position on 3 Tesla clinical MRI scanners
(Achieva, Phillips Healthcare, Best, The Netherlands)
equipped with dedicated phased-array bilateral breast
coils (SENSE-Breast7TX and SENSE-Breast-4 MRI
devices).
MRI imaging was performed according to our standard
staging breast imaging protocol, which included a trans-
verse high-resolution T1-weighted isotropic volume exam-
ination (THRIVE) [TE/TR 1.87/4.9 ms; flip angle 10°; FOV
360 × 360 × 180 mm3, acquired voxel size 0.65 × 0.65 ×
2.0 mm3, reconstructed voxel size 0.64 × 0.64 × 1.00 mm3)
and a transverse SPAIR T2-weighted series (TE/TR 100/
5508 ms; inversion delay SPAIR 305 ms; flip angle 90°; FOV
360 × 360 × 180 mm3, acquired voxel size 1.00 · 1.46 ·
2.0 mm3, reconstructed voxel size 0.64 · 0.64 · 2.00 mm3).
The dynamic series consisted of contrast-enhanced fat-
suppressed T1-weighted gradient echo images (TE/TR
1.24/3.3 ms; flip angle 10°; FOV 360 · 360 × 180 mm3, ac-
quired voxel size 1.00 · 1.00 · 2.00 mm3, reconstructed
voxel size 0.94 · 0.94 · 1.00 mm3; dynamic scan duration
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206, 274 and 342 seconds after the administration of
0.1 mmol/kg Gadolinium-DTPA (Magnevist, Schering,
Germany). The acquisition time of this scan package was
approximately 25 minutes.
Image interpretation
Mammograms and US images were retrieved from
the local PACS system and analyzed at a Sectra
Workstation IDS7 (Sectra Imtec AB, Sweden). MRI
examinations were processed by CADstream (Con-
firma, Inc., Kirkland, WA, USA). The images were
interpreted by two dedicated breast radiologists. In
addition, all images were reviewed and interpreted by
a third radiologist, who was blinded to the proportion
of the lobular component of each patient. In case of
discordance with the original reports, a consensus
was reached with a fourth dedicated breast radiologist
with more than 20 years of experience in breast
imaging.
All images were interpreted according to the guide-
lines of the BI-RADS® lexicon (D’Orsi & Dea 2003). Le-
sions were essentially divided into mass and non-mass-
like lesions in order to perform morphological analysis.
Based on the BI-RADS® lexicon, (D’Orsi & Dea 2003) le-
sions which had a mass as the main characteristic [iso-
lated mass or dominant mass surrounded by smaller
masses or foci of non-mass like enhancement (NMLE)]
were defined as a mass-like lesion. Architectural distor-
tion and NMLE (focal area, linear, ductal, segmental, re-
gional, multiple regions, diffuse enhancement, and
multiple enhancing foci) were defined as descriptors of
non-mass-like lesion. Time intensity curves were classi-
fied according to their pattern of initial rise (slow,
medium, rapid) and according to the delayed phase (per-
sistent, plateau, washout). Finally, each lesion was scored
according to the BI-RADS® lexicon; (D’Orsi & Dea 2003)
0 – Finding for which additional evaluation is needed, 1
– No abnormal enhancement, no lesion found, 2 – Be-
nign finding, 3 – Probably benign finding, (short interval
follow-up), 4 – Suspicious abnormality, 5 – Highly sug-
gestive of malignancy, 6 – Known cancer biopsy-proven
malignancy diagnosis on the imaged finding prior to de-
finitive therapy.
Tumor extent and additional disease were defined as
follows:
 Multifocality: an additional malignant lesion in the
same quadrant, separated from the index tumor by
benign tissue.
 Multicentricity: an additional malignant lesion in a
different quadrant than the index cancer.
 Contralateral disease: an additional malignant lesion
found in contralateral breast. Multiplicity: two or more of these features:
multifocality, multicentricity and contralateral
disease.
Additional findings were considered true positives
when histopathological analysis of either preoperative
work-up or surgical specimen has shown malignancy
[invasive carcinoma or ductal carcinoma in situ (DCIS)].
Histological analysis
All slices of ductolobular carcinoma (n = 113) were
reviewed by a dedicated breast radiologist to quantify
the lobular component, defined as a proportion of the
invasive cancer.
Statistical analysis
Data were analysed using SPSS 17.0 software (SPSS, Inc.,
Chicago, IL, USA). Chi – square tests were used to com-
pare proportions of the lobular component to the imaging
characteristics and to compare the proportions of lobular
component to the additional findings in our sample. For
statistical purpose, proportion of the lobular component
was grouped into three different categories: ≤ 20%, 21 –
94%, and ≥ 95%. Results were considered significant at
p < 0.05.
Results
Between January 2008 and October 2012, 505 patients
were diagnosed with breast cancer and invasive ductal
carcinoma with lobular features was reported in 30%
(155/505) of the patients. Of these 155, 41 patients were
excluded due to technical problems in performing MRI,
obesity, claustrophobia, impossibility of obtaining mam-
mography or ultrasound before MRI and personal rea-
sons. The remaining 113 patients who underwent
mammography, ultrasound and MRI were selected for
this study. The age at diagnosis of the 113 patients
ranged from 34 to 87 years with a mean of 57.4 years.
There were 41 patients with a proportion of ≤ 20% of
lobular component, 36 patients with a proportion of 21 to
94%, and 36 patients with ≥ 95% of lobular component.
Mammographic findings
Mammographic findings are presented in Table 1. A
mass was the most common mammographic finding,
observed in 54.8% of cases. In 46.0% of cases, we found
an isolated mass and, in 8.8%, a mass was found associ-
ated with microcalcifications. Isolated microcalcifications
were seen in 11.5% of the patients. Architectural distor-
tion was found in 10.6% of cases and asymmetries (asso-
ciated or not with microcalcifications) were noticed in
8.1% of cases. Normal findings were observed in 15.0%
of the patients.
Table 1 Mammographic findings of invasive ductolobular
carcinomas of the breast
Findings n = 113
Benign/Normal 15.0% (17/113)
Mass 46.0% (52/113)
Mass with calcification 8.8% (10/113)
Calcification only 11.5% (13/113)
Architectural distortion 10.6% (12/113)
Focal asymmetry or asymmetry 7.1% (8/113)
Asymmetry and calcification 1.0% (1/113)




Mass Margin n = 62
Circunscribed 4.8% (3/62)
Not Circunscribed 24.2% (15/62)
Spiculated 71.0% (44/62)
Mass Density n = 62
Isodense 88.7% (55/62)
Hyperdense 11.3% (7/62)
Associated Findings n = 113
Nipple retraction 3.5% (4/113)
Skin Thickening 10.6% (12/113)
Enlarged axillary lymph nodes 3.5% (4/113)
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patients with ≥ 95% of lobular component vs. 12.2% in
the ≤ 20% lobular component group (Table 2). However,
this difference had no statistical significance (p = 0.115).
Considering only mass lesions (n = 62), a total of
62.9% were simultaneously irregular, spiculated and iso-
dense to the fibroglandular parenchyma (Figure 1a). Iso-
dense mass was more frequently associated with smaller
lobular component (p = 0.016). Circumscribed masses
were seen in 2.6% (3/113) of the patients.Table 2 Imaging findings of invasive ductolobular
carcinomas of the breast according to proportion of the
lobular component
Proportion lobular component
Findings ≤ 20% 21 – 94% ≥ 95%
(n = 41) (n = 36) (n = 36)
Normal Mammographic Findings 12.2% (5) 8.3% (3) 25.0% (9)
Multifocality 21.9% (9) 27.7% (10) 33.3% (12)
Multicentricity 9.7% (4) 19.4% (7) 25.0% (9)
Contralateral Disease 9.7% (4) 11.1% (4) 16.6% (6)
Multiplicity 7.3% (3) 13.8% (5) 30.5% (11)The prevalence of other mammographic lesions
(microcalcifications, architectural distortion, asymmet-
ries), mass shape and mass margins did not vary signifi-
cantly according to the proportion of the lobular
component.
Additional findings (nipple retraction and skin thicken-
ing) were seen in 14.1% (16/113) of the patients (Figures 2a
and 3a).
Ultrasound findings
Ultrasound findings are summarized in Table 3. Of the
113 cancers, 109 (96.5%) lesions were masses localized
in the breast, 3 (2.6%) patients had normal exams and 1
(0.9%) patient had a parasternal mass. These masses
(n = 109) found in our study were mainly irregular
(92.7%), spiculated (60.6%), hypoechoic (91.8%), with
posterior acoustic shadowing (64.2%). These four charac-
teristics were observed simultaneously in 46.8% of the
patients (Figures 1b and 4b). Microlobulated margin was
seen in 19.3% of the patients and absence of posterior
acoustic features was found in 30.3% of cases.
Taking into account the lobular component, angular
margins were more prevalent in patients with a bigger
lobular component, with 11.1% in the ≥ 95% group and
4.8% in the ≤ 20% group. However, these results had no
statistical significance. Findings concerning to mass
shape, echogenicity and posterior acoustic features had
similar prevalence in all groups.
MRI findings
Of all tumors (n = 113), 89.4% (101) were classified as
“mass-like” lesion (see Table 4). From these 101, 56.4%
were isolated masses, 37.6% were a dominant mass asso-
ciated with NMLE features and 6.0% were dominant
masses surrounded by smaller masses. The most com-
mon findings for mass lesions were low signal on T1 in
99.0% of cases and moderate signal in 43.6% of cases on
T2-weighted images. Concerning mass shape, the masses
found were predominately irregular (86.1%). Regarding
the margins of these masses, spiculated or irregular mar-
gins were found in 91.1%. Heterogeneous enhancement
pattern was seen in 59.4% of cases.
39.8% of patients presented with NMLE features and
they could be found isolated or associated with other le-
sions (adjacent to a dominant mass or to an architec-
tural distortion). Considering all cases with NMLE
features found in our sample (45 in total), 71.1% pre-
sented as focal areas. The internal enhancement was
homogeneous in 69.0% and all cases were asymmetric.
Lesions with isolated NLME aspect were seen in 5.3%
(6/113) of our patients. Architectural distortion and
architectural distortion associated with NMLE were seen
in 2.6% and 0.9% of the patients, respectively. Normal
exams were found in 2 patients (1.8%).
Figure 1 48 year old woman, with positive family history for breast cancer, presented with a palpable lump on the left breast, finally
diagnosed as ductolobular carcinoma with a ≤ 20% proportion of the lobular component. a) Mediolateral oblique and craniocaudal
mammograms show an irregular and spiculated mass. A comet-tail like projection arises from the anterior and posterior margins and a discrete
retraction around the lesion can be seen. b) Ultrasound of the left breast demonstrates an irregular, hypoechoic and vertically oriented mass, with
echogenic halo at 3 o’clock position.
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(n = 103), rapid initial rise was seen in 86.4% of cases
and in 61.2% of cases had washout pattern in delayed
phase. In 7.1% of cases, kinetic data was not available
and 6.8% of the patients showed benign pattern (persist-
ent curve) in delayed phase. In kinetic delayed phase,
“plateau” curve was more frequently observed in cases
with bigger lobular component (36% in both the 21 –
94% and ≥ 95% groups vs. 17% in the ≤ 20% group)
(Figures 3c, d and 5c). Washout was more prevalent in
tumors with a smaller lobular component (63.4% in the ≤
20% group vs. 50.0% in the ≥ 95% group) (Figure 2e) . Des-
pite these differences, there was no statistical relevant dif-
ference among those groups (p≥ 0.05). Mass shape, mass
margins, patterns of mass enhancement and NMLE charac-
teristics did not show statistical significant variations ac-
cording to the proportion of the lobular component.
We found 46 associated findings in 36 patients
(31.8%), such as nipple retraction, skin thickening (focal
or diffuse), edema, hematoma/blood and pre-contrast
high ductal signal. Invasion of the pectoral muscle, con-
firmed by histopathological analysis, was found in 5
(4.4%) patients, nipple invasion in 3 (2.6%) patients and
skin invasion in 2 (1.8%) cases. Chest wall invasion was
seen in 1 (0.9%) patient, associated to pectoral muscle
ingrowth and, in 2 (1.8%) cases, nipple, skin and pectoral
muscle ingrowth were found together (Figures 2b, c, d,
3b and 5a).Lymphadenopathy
Lymph node metastasis was histologically reported in 57
patients. From these, 38.5% were seen by imaging. In 5
cases, lymphadenopathy was seen both in MRI and US
and in 3 cases it was seen in MRI, US and mammog-
raphy. Prevalence of lymphadenopathy did not show sig-
nificant differences according to proportion of the
lobular component.Additional findings
Multifocality and Multicentricity were found in 31
(27.4%) and 20 (17.7%) patients respectively. Multiplicity
was found in 19 cases (16.8%) and contralateral disease
was seen in 14 (12.3%) patients (Figure 2c and 4b). Tak-
ing into account the proportion of lobular component,
contralateral disease, multifocality and multicentricity
had higher prevalence rates in patients with bigger lobu-
lar component (Table 2), but there was no statistical sig-
nificance. Nevertheless, multiplicity was more likely to
be found in patients with a bigger lobular component
(p = 0.021).Size
At mammography and US, tumor size ranged from 4 to
6.0 cm (mean, 1.78 cm) and on MRI tumor size ranged
from 2 to 9.4 cm (mean, 2.50 cm). The sizes found on
pathology ranged from 2 to 12.0 cm (mean, 2.9 cm).Discussion
Mammography
The characteristics of IDC and ILC have been exten-
sively described in literature. The dispersed infiltrating
growth pattern of ILC with very little desmoplastic reac-
tion and, consequently, the development of palpable le-
sion or tumors detectable in imaging exams, is less
frequent. Normal or benign findings are more common
in ILC than in IDC (8%–16% vs. 1.1%) (Li et al. 2003;
Kim et al. 2011; Selinko et al. 2004; Mann et al. 2008)
and false negative rates for ILC in mammography range
from 14 to 19% (Kim et al. 2011; Hilleren et al. 1991b;
Krecke & Gisvold 1993).
In the current study, we observed 15% (17/113) of
normal or benign mammograms, which might demon-
strate a similar behavior to ILC. It was also interesting
that patients with tumors with ≥ 95% of lobular compo-
nent had a higher prevalence of normal findings in
Figure 2 59 year-old patient with mastitis carcinomatosa (inflammatory carcinoma), finally diagnosed as ductolobular carcinoma with
a ≥ 95% proportion of the lobular component. a) Craniocaudal and mediolateral mammograms show extensive skin and trabecular
thickening/coarsening of the right breast and diffusely increased breast density, associated with multiple calcifications in the upper outer breast.
b) MRI shows multiple confluent masses, with irregular margins and heterogeneous internal enhancement pattern. Skin thickening and invasion
of the nipple and the pectoral muscle are also observed. These are the typical features of inflammatory carcinoma. Multicentricity (multifocal and
multicentric disease simultaneously) can also be observed in coronal projection (c). d and e) Post-processed color parametric map image
demonstrates multiple areas of malignant enhancement in axial projection. Kinetic curve demonstrates typical malignant pattern (rapid initial rise
and washout).
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ponent (25 vs. 12%, respectively), but these differences
were not statistically significant.
ILC is usually seen as a mass (44%–65% of cases), (Lopez
& Bassett 2009; Helvie et al. 1993) having predominantly ir-
regular and spiculated margins (63-71%) (Helvie et al. 1993;
Evans et al. 2002) and is usually isodense when compared
to the fibroglandular tissue (Kim et al. 2011; Lopez &
Bassett 2009; Sickles 1991). These numbers were similar to
our present findings. Mass was found in 54.8% of oursample and 62.9% of these masses were simultaneously
irregular, spiculated and isodense.
ILC spreading diffusely through the breast stroma leads
to lower tendency to form round and circumscribed
masses, only seen 1%–3% of cases of ILC (Le et al. 1992).
The lobular component of ductolobular tumors might lead
to a similar behavior and, in our study, circumscribed
masses were indeed only found in 2.6% of our cases.
Architectural distortion was seen in 10.6% of cases
and asymmetries were found in 7.9% of cases. Literature
Figure 3 52 year-old woman with nipple retraction and metastasis to the right eye, finally diagnosed as ductolobular carcinoma with
a 21 – 94% proportion of the lobular component. a) Left mediolateral oblique and craniocaudal mammograms show a star shaped mass in
center of the breast, associated with calcifications, skin thickening and nipple retraction. b) Axial contrast material-enhanced with fat suppression
show a spiculated mass. There is nipple retraction, skin thickening and pectoral muscle invasion. c and d) Post-processed color parametric map
and kinetic curve predominantly demonstrate persistent enhancement and a small central area of plateau.
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architectural distortion (Hilleren et al. 1991b; Helvie
et al. 1993) and 4%–13% of cases expressing as asym-
metries (Hilleren et al. 1991b; Helvie et al. 1993). Our
findings are comparable to these ILC mammographic le-
sions. However, architectural distortion is the second
most common finding in ILC (Hilleren et al. 1991b;
Helvie et al. 1993) and architectural distortion was the
third most common radiological abnormality in our study.
It is well known that microcalcifications are much less
common when comparing ILC and other breast carcin-
omas (4-24% vs. 41%) (Le et al. 1992). The prevalence of
microcalcifications in our study was similar to the re-
ferred prevalence of these findings in ILC (11.5%).
Ultrasonography
US is considered more sensitive than mammography in
detecting ILC. Literature reports sensitivities ranging
from 68 to 98% (Paramagul et al. 1995; Selinko et al.
2004) and this imaging modality is also more accurate in
identifying multifocality, multicentricity and size of the
lesion (Selinko et al. 2004). According to Kim and Butler,
mass has been described as being the most common le-
sion found in US in cases of ILC (60.5 – 100%) and both
authors agreed that an irregular, hypoechoic mass, withspiculated margins and posterior acoustic shadowing is
the most ordinary pattern seen in US images of ILC
(Kim et al. 2011; Butler et al. 1999). Our results are con-
sistent with these numbers. However, Kim et al. de-
scribed US features of ILC and IDC as being very
similar, except for posterior acoustic features, which has
been described as being more related to ILC (Kim et al.
2011).
MR imaging
MRI has proven to have a high overall sensitivity (ap-
proximately 95%) (Mann et al. 2008; Kneeshaw 2003)
and, in adjunct to mammography and US, has an essen-
tial importance in diagnostic and staging of ILC. MRI
has a moderate specificity (67.4%) (Bluemke et al. 2004)
and the routinely clinical use of this imaging modality
might lead to unnecessary procedures (Peters et al.
2011). However, in ILC cases, MRI is superior to other
imaging modalities in estimating tumor size, detecting
multifocality, multicentricity, contralateral disease
(Boetes et al. 1995; Orel et al. 1994; Rodenko et al. 1996;
Mann et al. 2008; Peters et al. 2011; Lesser et al. 1982).
and also affecting surgical management in 28% of cases
(Mann et al. 2008; Weinstein 2001). Mass is considered
the most common manifestation of ILC at MRI and the
Table 3 Ultrasonographic findings of invasive
ductolobular carcinomas of the breast
Findings n = 113
Benign 2.6% (3/113)
Mass 96.5% (109/113)
Other findings (parasternal mass) 0.9% (1/113)
Mass Shape n = 109
Round/Oval 7.3% (8/109)
Irregular 92.7% (101/109)






Mass Echogenicity n = 109
Complex echoic 6.4% (7/109)
Hypoechoic 91.8% (100/109)
Isoechoic 1.8% (2/109)
Mass Posterior acoustic feature n = 109
No feature 30.3% (33/109)
Enhancement 5.5% (6/109)
Shadowing 64.2% (70/109)
Associated Findings n = 113
Enlarged axillary lymph nodes 8.8% (10/113)
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2011; Rodenko et al. 1996; Schelfout 2004; Weinstein
2001; Yeh et al. 2003). Most of these studies have not
described ILC findings in MRI strictly according to the
BI-RADS® lexicon. However, Hye Na Jung and Kim
found 92% and 88.8% of ILC cases presented as mass -Figure 4 A 43 year old woman presenting with focal thickening in th
a ≤ 20% proportion of the lobular component. a) Mediolateral and cran
the upper outer quadrant. b) Ultrasound shows a hypoechoic and spiculat
(upper outer quadrant).like lesion according to the BI-RADS® (Kim et al. 2011;
Jung et al. 2013). These findings are consistent with our
research (89.4% of cases presenting as mass - like
tumors).
In a literature review, Mann et all described 85.5%
(65/76) of ILC tumors presenting as an irregular or spi-
culated mass (Mann et al. 2008). Our study had similar
results and 91% (92/101) of the lesions were described
as irregular or spiculated masses.
T1 and T2 features of lobular tumors are not fre-
quently mentioned in literature. Levrini reported 95.2%
(20/21) of cases of ILC tumors being hypo- and hyperin-
tense lesions on T2 weighted TSE images (Levrini et al.
2008). Unfortunately all of our patients underwent diag-
nostic procedures within 10 days before MRI. The
hemorrhage, edema and necrosis that result from these
procedures may have changed T1 and/or T2 signal,
which makes an accurate analysis more difficult.
Not many studies refer to the kinetic behavior of ILC.
The infiltrative growth pattern of these tumors seems
not to require extensive neovascularization and the lack
of endothelial growth factor found in lobular tumors
turns the new vessels to grow more slowly and having
better maturation, resulting in less permeable capillaries
(Lee et al. 1998). Some studies found ILC having delayed
maximum enhancement and wash out pattern was not
observed in the majority of tumors (Trecate et al. 2001;
Sittek et al. 1998). These features might be due the
histological behavior of ILC. Indeed, the prevalence of
“plateau” curve in our study was higher in groups of pa-
tients with higher lobular component, and washout was
more prevalent in groups of patients with lower lobular
component. However, these differences were not statisti-
cally significant.
More recent studies refer 70.3% to 95.2% of ILC lesions
having washout pattern (Kim et al. 2011; Levrini et al. 2008;
Mann et al. 2011). Considering all available kinetic curves
and not taking into account the proportion of the lobulare left breast, finally diagnosed as ductolobular carcinoma with
iocaudal mammograms of the left breast show a spiculated mass in
ed mass, with echogenic halo at and posterior acoustic shadowing
Table 4 MRI findings of invasive ductolobular carcinomas
of the breast according to the BI-RADS® (NMLE = non-mass
like enhancement)
Lesion Type n = 113
Normal 1.8% (2/113)
Massa 55.8% (63/113)
Mass + NMLE 33.6% (38/113)
NMLE 5.3% (6/113)
Architectural distortion 2.6% (3/113)
Architectural distortion + NMLE 0.9% (1/113)




High central low peripheric 1.0% (1/101)




Low central high peripheric 10.9% (11/101)








Mass Enhancement n = 101
Homogeneous 15.8% (16/101)
Heterogeneous 59.4% (60/101)
Rim enhancement 24.8% (25/101)
Dark internal septation 0% (0/101)
Enhancing internal septation 0% (0/101)
Central enhancement 0% (0/101)
NMLE Distribution n = 45





Multiple Regions 6.7% (3/45)
Diffuse 2.2% (1/45)
NMLE Internal Enhancement n = 45
Homogeneous 69.0% (31/45)
Heterogeneous 22.2% (10/45)
Table 4 MRI findings of invasive ductolobular carcinomas
of the breast according to the BI-RADS® (NMLE = non-mass
like enhancement) (Continued)
Stippled, punctate 0% (0/45)
Clumped 4.4% (2/45)
Reticular, dendritic 0% (0/45)
Rim enhancement 4.4% (2/45)
NMLE Symmetry n = 45
Symmetric 0% (0/45)
Asymmetric 100.0% (45/45)
Kinetic Pattern Initial Rise n = 113




Kinetic Pattern Delayed Phase n = 113




a Isolated mass or dominant mass surrounded by smaller masses.
b Excluding non-available and normal exams (n = 103).
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analysis (61.2%), but still lower than the numbers referred
from these authors. However, Mann at al. showed that
when CAD-application was used to evaluate the kinetic
curve of lesions of ILC and IDC, washout pattern has a very
similar prevalence in both tumors, which is not the case for
visual assessment. In this latter case, IDC has a much
higher prevalence of washout than ILC (Mann et al. 2011).
The use of CADstream software to obtain the kinetic
curves in our study might be the explanation for the higher
washout pattern prevalence.
Lymphadenopathy
Arps et al. described IDC-L as having a higher frequency
of nodal metastasis when compared to IDC and ILC (51
vs. 34 and 45%, respectively) (Arps et al. 2013). A similar
result was seen in our study and lymph node metastasis
was found in 50.4% of our sample (57/113), even though
there was no statistical significance between prevalence
of lymphadenopathy and proportions of lobular
component.
Additional findings
Since comprehensive studies about mixed tumors are
missing in literature, it is difficult to put our present re-
sults into perspective. Arps et al. compared clinicopatho-
logic features and outcomes of 183 cases of IDC-L with
lobular features with 1499 patients with IDC and 375
Figure 5 49 year-old patient with palpable thickening in the right breast, finally diagnosed as ductolobular carcinoma with a ≤ 20%
proportion of the lobular component. a) Multiple irregular, confluent and heterogeneous masses in the right breast associated with skin
thickening and pectoral muscle invasion. b and c) Contralateral disease is better seen in color parametric map (axial projection). Observe the
enhancement pattern (rapid initial rise and plateau) commonly observed in invasive lobular carcinomas.
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copathologic features and outcomes of IDC-L and ILC
are very similar, irrespective of the proportion of the
lobular component (Arps et al. 2013).
In our study, not only imaging characteristics did not vary
significantly according to the lobular component, but also
multifocality, multicentricity, contralateral disease and the
proportions of lobular component did not show a statisti-
cally significant correlation.
However, the significant association between two or more
of these additional findings (multiplicity) and bigger lobular
component (p = 0.021) is in line with the higher rates of
additional disease foci in patients with ILC (Boetes et al.
1995; Orel et al. 1994; Rodenko et al. 1996; Mann et al.
2008; Peters et al. 2011; Lesser et al. 1982).
Conclusion
To our knowledge, this is the first study to exclusively
describe radiological features of invasive ductolobularcarcinoma. They typically present as an irregular, spicu-
lated and isodense mass at mammography, as a hypoe-
choic, irregular and spiculated mass with posterior
acoustic shadowing on US, and as an isolated mass or as a
dominant mass surrounded by smaller masses or NMLE
on MRI. Washout is the most ordinary kinetic pattern of
these tumors. Except for isodensity and multiplicity, the im-
aging characteristics did not vary significantly according to
proportion of the lobular component. The imaging features
and the high incidence of additional malignant imaging
findings of invasive ductolobular carcinoma are therefore
more similar to ILC than to IDC.Ethical standards
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